Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-05-07 9:48 pm Sale | 13D | ASCENDIS PHARMA A/S SPONSORED ASND | ORBIMED ADVISORS LLC | 2,518,782 5.2% | -493,118 (-16.37%) | View |
| 2020-03-04 7:26 pm Sale | 13D | ASCENDIS PHARMA A/S SPONSORED ASND | ORBIMED ADVISORS LLC | 3,011,900 6.3% | -385,773 (-11.35%) | View |
| 2020-02-14 4:34 pm Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | RA CAPITAL MANAGEMENT L.P. | 4,185,342 8.8% | 52,900 (+1.28%) | View |
| 2020-02-14 4:14 pm Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | BAKER BROS. ADVISORS LP | 3,390,270 7.1% | 552,918 (+19.49%) | View |
| 2020-02-14 1:30 pm Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | PRICE T ROWE ASSOCIATES INC | 7,761,296 16.2% | 2,022,036 (+35.23%) | View |
| 2020-02-07 11:12 am Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | FMR LLC | 4,773,953 9.999% | 570,707 (+13.58%) | View |
| 2019-10-23 4:11 pm Sale | 13D | ASCENDIS PHARMA A/S SPONSORED ASND | VIVO VENTURES VII LLC | 1,599,112 3.3% | -200,000 (-11.12%) | View |
| 2019-08-14 4:37 pm Sale | 13D | ASCENDIS PHARMA A/S SPONSORED ASND | ORBIMED ADVISORS LLC | 3,397,673 7.1% | -235,700 (-6.49%) | View |
| 2019-06-10 4:11 pm Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | PRICE T ROWE ASSOCIATES INC | 5,739,260 12.2% | 1,628,368 (+39.61%) | View |